Market revenue in 2023 | USD 42.0 million |
Market revenue in 2030 | USD 52.3 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.33% in 2023. Horizon Databook has segmented the France in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The market is driven by increasing prevalence of targeted diseases, technological advancements, and increasing adoption of quality control to monitor the accuracy of marketed tests in the country. Growing cases of cancer, infectious diseases, & other medical conditions and increasing initiatives undertaken by market players & government bodies are expected to boost the IVDs quality control market growth.
In France, there are around 100 companies involved in the manufacturing of IVD products. These companies include several global major manufacturers and many SMEs, which produce 7,000 out of 40,000 in vitro devices produced in Europe.
Privatization of diagnostic laboratories is propelling the demand for IVD quality control, which allows the labs to maintain accuracy of tests as per international standards. This improves the consumer confidence in the diagnostic laboratories, along with an increased reliability of results.
Horizon Databook provides a detailed overview of country-level data and insights on the France in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into France in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account